Sales of Takhzyro amounted to 44.1 billion Japanese yen in the 3rd quarter of 2022, an increase of 42.7% from the previous year. Takeda Pharmaceutical's revenue was $8,354 million in Q3 2022, showing ...

While only one of the pharmaceutical companies within the Fortune 500 states that they sell personal information, the company that has disclosed the sale of information is posting a “Do Not Sell My ...

Drug companies are under increasing pressure to keep prices under control. At a hearing on Capitol Hill Thursday, lawmakers from both sides of the... How Do Pharmaceutical Companies Establish Drug ...

In order to continue to be viable in the next decade, the pharmaceutical industry is adapting in ways that might seem surprising just a few years ago. The pressure to reduce costs coupled with the ...

Approximately 69% of pharmaceutical companies that deploy a significant number of third party behavioral advertising cookies on their websites do not utilize a cookie notice. The 31% of pharmaceutical ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. In today’s ever-changing market place, pharmaceutical companies are challenged to reach, ...

The pharmaceutical-sales field, often called "recession-proof," is popular because it offers excellent salary potential, great benefits, flexibility, opportunity for growth, and frequently the use of ...

In order to end this pandemic, everyone must play their part, and that includes the private sector. Their leadership, innovation, skills, knowledge, and financial muscle are desperately needed. This ...

When you’re sick with the flu and facing down a week of finals, thank a pharmaceutical chemist for the medicine that brings you relief. However, this major is about much more than treating illness — ...

Stop smoking. Eat more fruits and vegetables as well as fewer fatty foods. Get more exercise. Buckle up your seatbelt. Those are simple rules of good health that anyone can and should follow. But a ...

Much of the news people hear about pharmaceutical innovation has to do with clinical trials. So I’m writing a series of posts about these trials, which underlie regulatory approval of new medicines.

On this week’s JOURNAL, Bill Moyers spoke with Melody Petersen, an independent journalist who formerly covered the drug industry for the NEW YORK TIMES and is author of OUR DAILY MEDS: HOW THE ...